Optimizing immunomodulatory therapy for MS patients: an integrated management model-Reference-Cited by-同舟云学术

Optimizing immunomodulatory therapy for MS patients: an integrated management model

Published:2002-09 Issue:1-2 Volume:201 Page:89-90
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Jeffery Douglas,Bashir Khurram,Buchwald Linda,Coyle Patricia,Freedman Mark,Markowitz Clyde,Rammohan Kottil,Reder Tony,Sharief Mo,Wolinsky Jerry

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference7 articles.

1. Disease modifying therapies in multiple sclerosis: subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines;Goodin;Neurology,2002

2. Disease Management Consensus Statement,1998

3. Consensus statement of the Canadian MS clinics network on: the use of disease modifying agents in multiple sclerosis;Oger;Can. J. Neurol. Sci.,1999

4. International consensus statement on the use of disease-modifying agents in multiple sclerosis;Freedman;Mult. Scler.,2002

5. Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor definitive clinical trials;Paty;J. Neurol. Psychiatry,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis;Frontiers in Neurology;2020-09-02

2. Evaluating response to disease-modifying therapy in relapsing multiple sclerosis;Expert Review of Neurotherapeutics;2015-03-12

3. Financial Valuation Algorithm for the Assessmentof the Future Sales of a New, Innovative Medicinal Product;The Journal of Private Equity;2014-05-31

4. An agent-based simulation model for informed shared decision making in multiple sclerosis;Multiple Sclerosis and Related Disorders;2013-10

5. Neurophysiologische Diagnostik und Diagnosekriterien neuroimmunologischer Erkrankungen Multiple Sklerose;Das Neurophysiologie-Labor;2013-03